We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+6.57%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$49.1B
AUM Growth
+$4.31B
Cap. Flow
+$1.72B
Cap. Flow %
3.51%
Top 10 Hldgs %
14.46%
Holding
3,114
New
67
Increased
2,155
Reduced
468
Closed
57

Sector Composition

Rank Sector Weight
1 Financials 14.36%
2 Healthcare 13.62%
3 Technology 13.02%
4 Industrials 11.1%
5 Energy 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TUMI
1726
DELISTED
TUMI HLDGS INC COM
TUMI
$2.45M 0.01%
121,394
+9,853
+9% +$223K
ININ
1727
DELISTED
Interactive Intelligence Group, inc.
ININ
$2.45M 0.01%
37,946
+1,747
+5% +$103K
WW
1728
DELISTED
WW International
WW
$2.44M 0.01%
64,255
+2,585
+4% +$104K
IGTE
1729
DELISTED
IGATE CORPORATION
IGTE
$2.44M 0.01%
85,596
+6,184
+8% +$142K
PRK icon
1730
Park National Corp
PRK
$3.74B
$2.43M 0.01%
30,423
+1,053
+4% +$82.3K
IART icon
1731
Integra LifeSciences
IART
$1.42B
$2.43M 0.01%
145,093
-7,254
-5% -$116K
GMED icon
1732
Globus Medical
GMED
$11.5B
$2.43M ﹤0.01%
138,632
+45,248
+48% +$783K
ACAT
1733
DELISTED
Arctic Cat Inc
ACAT
$2.42M ﹤0.01%
41,986
+2,348
+6% +$128K
ROCK icon
1734
Gibraltar Industries
ROCK
$1.48B
$2.42M ﹤0.01%
169,455
+945
+0.6% +$13.6K
FBRC
1735
DELISTED
FBR & Co. Common Stock
FBRC
$2.4M ﹤0.01%
88,896
+53,460
+151% +$1.5M
VVUS
1736
DELISTED
Vivus Inc
VVUS
$2.39M ﹤0.01%
25,490
+1,773
+7% +$221K
HTS
1737
DELISTED
HATTERAS FINANCIAL CORP
HTS
$2.38M ﹤0.01%
127,479
-7,235
-5% -$146K
ARCC icon
1738
Ares Capital
ARCC
$14.5B
$2.38M ﹤0.01%
136,914
+8,014
+6% +$140K
AREX
1739
DELISTED
Approach Resources Inc.
AREX
$2.38M ﹤0.01%
82,829
+4,077
+5% +$103K
ILG
1740
DELISTED
ILG, Inc Common Stock
ILG
$2.38M ﹤0.01%
98,860
+7,752
+9% +$170K
RITM icon
1741
Rithm Capital
RITM
$5.77B
$2.37M ﹤0.01%
180,350
KG
1742
Kestrel Group
KG
$61.8M
$2.36M ﹤0.01%
9,867
+171
+2% +$42.5K
ASTE icon
1743
Astec Industries
ASTE
$979M
$2.36M ﹤0.01%
65,268
+1,618
+3% +$57.6K
LCI
1744
DELISTED
Lannett Company, Inc.
LCI
$2.35M ﹤0.01%
26,300
EPIQ
1745
DELISTED
EPIQ SYSTEMS INC
EPIQ
$2.35M ﹤0.01%
173,774
+1,174
+0.7% +$15.3K
WSFS icon
1746
WSFS Financial
WSFS
$4.16B
$2.35M ﹤0.01%
115,035
+2,859
+3% +$57.2K
IWV icon
1747
iShares Russell 3000 ETF
IWV
$20.6B
$2.35M ﹤0.01%
23,010
-1,990
-8% -$199K
ROIC
1748
DELISTED
Retail Opportunity Investments Corp.
ROIC
$2.34M ﹤0.01%
166,773
+21,589
+15% +$294K
NXGN
1749
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$2.34M ﹤0.01%
105,367
+14,407
+16% +$307K
ZNGA
1750
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$2.34M ﹤0.01%
608,471
+176,190
+41% +$556K

Similar funds

Charles Schwab's Q3 2013 Portfolio in Review

As of Q3 2013, Charles Schwab held 3,114 positions worth $49.1B, up 9.6% from $44.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab deployed $1.72B of net new capital in Q3 2013, opening 67 new positions and adding to 2,155 existing holdings. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 4,003,512 shares worth $136M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Merck, an estimated $76M trimmed.

  • Charles Schwab's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 4,003,512 shares worth $136M.
  • Charles Schwab added most to Johnson & Johnson in Q3 2013, an estimated $125M increase.
  • Charles Schwab's biggest Q3 2013 reduction was Merck, cutting an estimated $76M.
  • Charles Schwab fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $47.2M.
  • Charles Schwab's ten largest holdings make up 14% of its $49.1B portfolio in Q3 2013.
  • Charles Schwab opened 67 new positions and closed 57 in Q3 2013.
  • Charles Schwab's portfolio value rose 9.6% quarter-over-quarter to $49.1B.

Based on Charles Schwab's 13F filing for Q3 2013, filed 14 Nov 2013.